nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Doxorubicin—pancreatic cancer	0.524	1	CbGbCtD
Bimatoprost—Infection—Tamoxifen—pancreatic cancer	0.000662	0.00282	CcSEcCtD
Bimatoprost—Infection—Erlotinib—pancreatic cancer	0.000655	0.00279	CcSEcCtD
Bimatoprost—Connective tissue disorder—Irinotecan—pancreatic cancer	0.00065	0.00277	CcSEcCtD
Bimatoprost—Nervous system disorder—Erlotinib—pancreatic cancer	0.000646	0.00275	CcSEcCtD
Bimatoprost—Rhinitis—Gemcitabine—pancreatic cancer	0.000646	0.00275	CcSEcCtD
Bimatoprost—Skin disorder—Erlotinib—pancreatic cancer	0.00064	0.00273	CcSEcCtD
Bimatoprost—Pharyngitis—Gemcitabine—pancreatic cancer	0.000639	0.00272	CcSEcCtD
Bimatoprost—Visual impairment—Irinotecan—pancreatic cancer	0.000637	0.00271	CcSEcCtD
Bimatoprost—Rhinitis—Fluorouracil—pancreatic cancer	0.000635	0.0027	CcSEcCtD
Bimatoprost—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000635	0.0027	CcSEcCtD
Bimatoprost—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000633	0.0027	CcSEcCtD
Bimatoprost—Inflammation—Epirubicin—pancreatic cancer	0.000633	0.0027	CcSEcCtD
Bimatoprost—Skin discolouration—Doxorubicin—pancreatic cancer	0.000629	0.00268	CcSEcCtD
Bimatoprost—Pharyngitis—Fluorouracil—pancreatic cancer	0.000629	0.00268	CcSEcCtD
Bimatoprost—Cough increased—Doxorubicin—pancreatic cancer	0.000621	0.00264	CcSEcCtD
Bimatoprost—Lacrimation increased—Doxorubicin—pancreatic cancer	0.000616	0.00263	CcSEcCtD
Bimatoprost—Liver function test abnormal—Docetaxel—pancreatic cancer	0.00061	0.0026	CcSEcCtD
Bimatoprost—Cough—Sunitinib—pancreatic cancer	0.00061	0.0026	CcSEcCtD
Bimatoprost—Dry skin—Docetaxel—pancreatic cancer	0.000606	0.00258	CcSEcCtD
Bimatoprost—Hypertension—Sunitinib—pancreatic cancer	0.000603	0.00257	CcSEcCtD
Bimatoprost—Insomnia—Tamoxifen—pancreatic cancer	0.000602	0.00257	CcSEcCtD
Bimatoprost—Angiopathy—Irinotecan—pancreatic cancer	0.0006	0.00256	CcSEcCtD
Bimatoprost—Cystitis noninfective—Epirubicin—pancreatic cancer	0.0006	0.00255	CcSEcCtD
Bimatoprost—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000596	0.00254	CcSEcCtD
Bimatoprost—Insomnia—Erlotinib—pancreatic cancer	0.000596	0.00254	CcSEcCtD
Bimatoprost—Chest pain—Sunitinib—pancreatic cancer	0.000595	0.00253	CcSEcCtD
Bimatoprost—Dyspnoea—Tamoxifen—pancreatic cancer	0.000594	0.00253	CcSEcCtD
Bimatoprost—Cystitis—Epirubicin—pancreatic cancer	0.000593	0.00253	CcSEcCtD
Bimatoprost—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000591	0.00252	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000591	0.00252	CcSEcCtD
Bimatoprost—Dyspnoea—Erlotinib—pancreatic cancer	0.000587	0.0025	CcSEcCtD
Bimatoprost—Dyspepsia—Tamoxifen—pancreatic cancer	0.000586	0.0025	CcSEcCtD
Bimatoprost—Inflammation—Doxorubicin—pancreatic cancer	0.000586	0.00249	CcSEcCtD
Bimatoprost—Angiopathy—Gemcitabine—pancreatic cancer	0.000584	0.00249	CcSEcCtD
Bimatoprost—Dry mouth—Sunitinib—pancreatic cancer	0.000582	0.00248	CcSEcCtD
Bimatoprost—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000581	0.00247	CcSEcCtD
Bimatoprost—Dyspepsia—Erlotinib—pancreatic cancer	0.00058	0.00247	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000575	0.00245	CcSEcCtD
Bimatoprost—Pain—Tamoxifen—pancreatic cancer	0.000569	0.00243	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000569	0.00242	CcSEcCtD
Bimatoprost—Dry eye—Epirubicin—pancreatic cancer	0.000567	0.00242	CcSEcCtD
Bimatoprost—Infection—Sunitinib—pancreatic cancer	0.000567	0.00241	CcSEcCtD
Bimatoprost—Pain—Erlotinib—pancreatic cancer	0.000563	0.0024	CcSEcCtD
Bimatoprost—Erythema—Gemcitabine—pancreatic cancer	0.000561	0.00239	CcSEcCtD
Bimatoprost—Nervous system disorder—Sunitinib—pancreatic cancer	0.000559	0.00238	CcSEcCtD
Bimatoprost—Bladder pain—Epirubicin—pancreatic cancer	0.000555	0.00236	CcSEcCtD
Bimatoprost—Cystitis noninfective—Doxorubicin—pancreatic cancer	0.000555	0.00236	CcSEcCtD
Bimatoprost—Skin disorder—Sunitinib—pancreatic cancer	0.000554	0.00236	CcSEcCtD
Bimatoprost—Erythema—Fluorouracil—pancreatic cancer	0.000551	0.00235	CcSEcCtD
Bimatoprost—Cystitis—Doxorubicin—pancreatic cancer	0.000549	0.00234	CcSEcCtD
Bimatoprost—Dry eye—Doxorubicin—pancreatic cancer	0.000525	0.00224	CcSEcCtD
Bimatoprost—Vision blurred—Fluorouracil—pancreatic cancer	0.00052	0.00221	CcSEcCtD
Bimatoprost—Vertigo—Irinotecan—pancreatic cancer	0.000517	0.0022	CcSEcCtD
Bimatoprost—Insomnia—Sunitinib—pancreatic cancer	0.000516	0.0022	CcSEcCtD
Bimatoprost—Bladder pain—Doxorubicin—pancreatic cancer	0.000514	0.00219	CcSEcCtD
Bimatoprost—Dyspnoea—Sunitinib—pancreatic cancer	0.000508	0.00217	CcSEcCtD
Bimatoprost—Cough—Irinotecan—pancreatic cancer	0.000502	0.00214	CcSEcCtD
Bimatoprost—Dyspepsia—Sunitinib—pancreatic cancer	0.000502	0.00214	CcSEcCtD
Bimatoprost—Hypertension—Irinotecan—pancreatic cancer	0.000497	0.00212	CcSEcCtD
Bimatoprost—Eye pain—Epirubicin—pancreatic cancer	0.000494	0.0021	CcSEcCtD
Bimatoprost—Tafluprost—PTGS2—pancreatic cancer	0.000493	1	CrCbGaD
Bimatoprost—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000492	0.0021	CcSEcCtD
Bimatoprost—Cough—Gemcitabine—pancreatic cancer	0.000489	0.00208	CcSEcCtD
Bimatoprost—Pain—Sunitinib—pancreatic cancer	0.000488	0.00208	CcSEcCtD
Bimatoprost—Hypertension—Gemcitabine—pancreatic cancer	0.000484	0.00206	CcSEcCtD
Bimatoprost—Asthenia—Tamoxifen—pancreatic cancer	0.000478	0.00204	CcSEcCtD
Bimatoprost—Chest pain—Gemcitabine—pancreatic cancer	0.000477	0.00203	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000474	0.00202	CcSEcCtD
Bimatoprost—Asthenia—Erlotinib—pancreatic cancer	0.000473	0.00201	CcSEcCtD
Bimatoprost—Pruritus—Tamoxifen—pancreatic cancer	0.000471	0.00201	CcSEcCtD
Bimatoprost—Chest pain—Fluorouracil—pancreatic cancer	0.000469	0.002	CcSEcCtD
Bimatoprost—Infection—Irinotecan—pancreatic cancer	0.000467	0.00199	CcSEcCtD
Bimatoprost—Pruritus—Erlotinib—pancreatic cancer	0.000466	0.00199	CcSEcCtD
Bimatoprost—Nervous system disorder—Irinotecan—pancreatic cancer	0.000461	0.00196	CcSEcCtD
Bimatoprost—Rhinitis—Docetaxel—pancreatic cancer	0.000458	0.00195	CcSEcCtD
Bimatoprost—Eye pain—Doxorubicin—pancreatic cancer	0.000457	0.00195	CcSEcCtD
Bimatoprost—Infection—Gemcitabine—pancreatic cancer	0.000455	0.00194	CcSEcCtD
Bimatoprost—Pharyngitis—Docetaxel—pancreatic cancer	0.000454	0.00193	CcSEcCtD
Bimatoprost—Oedema peripheral—Docetaxel—pancreatic cancer	0.00045	0.00192	CcSEcCtD
Bimatoprost—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000449	0.00191	CcSEcCtD
Bimatoprost—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000449	0.00191	CcSEcCtD
Bimatoprost—Infection—Fluorouracil—pancreatic cancer	0.000447	0.0019	CcSEcCtD
Bimatoprost—Diplopia—Epirubicin—pancreatic cancer	0.000446	0.0019	CcSEcCtD
Bimatoprost—Skin disorder—Gemcitabine—pancreatic cancer	0.000445	0.00189	CcSEcCtD
Bimatoprost—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000441	0.00188	CcSEcCtD
Bimatoprost—Visual impairment—Docetaxel—pancreatic cancer	0.000441	0.00188	CcSEcCtD
Bimatoprost—Dizziness—Tamoxifen—pancreatic cancer	0.00044	0.00188	CcSEcCtD
Bimatoprost—Dizziness—Erlotinib—pancreatic cancer	0.000436	0.00186	CcSEcCtD
Bimatoprost—Eye disorder—Docetaxel—pancreatic cancer	0.000427	0.00182	CcSEcCtD
Bimatoprost—Insomnia—Irinotecan—pancreatic cancer	0.000425	0.00181	CcSEcCtD
Bimatoprost—Rash—Tamoxifen—pancreatic cancer	0.00042	0.00179	CcSEcCtD
Bimatoprost—Dermatitis—Tamoxifen—pancreatic cancer	0.000419	0.00179	CcSEcCtD
Bimatoprost—Dyspnoea—Irinotecan—pancreatic cancer	0.000419	0.00178	CcSEcCtD
Bimatoprost—Somnolence—Irinotecan—pancreatic cancer	0.000418	0.00178	CcSEcCtD
Bimatoprost—Headache—Tamoxifen—pancreatic cancer	0.000417	0.00178	CcSEcCtD
Bimatoprost—Rash—Erlotinib—pancreatic cancer	0.000415	0.00177	CcSEcCtD
Bimatoprost—Dermatitis—Erlotinib—pancreatic cancer	0.000415	0.00177	CcSEcCtD
Bimatoprost—Angiopathy—Docetaxel—pancreatic cancer	0.000415	0.00177	CcSEcCtD
Bimatoprost—Insomnia—Gemcitabine—pancreatic cancer	0.000414	0.00176	CcSEcCtD
Bimatoprost—Dyspepsia—Irinotecan—pancreatic cancer	0.000414	0.00176	CcSEcCtD
Bimatoprost—Headache—Erlotinib—pancreatic cancer	0.000413	0.00176	CcSEcCtD
Bimatoprost—Diplopia—Doxorubicin—pancreatic cancer	0.000412	0.00176	CcSEcCtD
Bimatoprost—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000412	0.00175	CcSEcCtD
Bimatoprost—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000411	0.00175	CcSEcCtD
Bimatoprost—Asthenia—Sunitinib—pancreatic cancer	0.000409	0.00174	CcSEcCtD
Bimatoprost—Dry skin—Epirubicin—pancreatic cancer	0.000409	0.00174	CcSEcCtD
Bimatoprost—Dyspnoea—Gemcitabine—pancreatic cancer	0.000408	0.00174	CcSEcCtD
Bimatoprost—Insomnia—Fluorouracil—pancreatic cancer	0.000407	0.00173	CcSEcCtD
Bimatoprost—Somnolence—Gemcitabine—pancreatic cancer	0.000407	0.00173	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000406	0.00173	CcSEcCtD
Bimatoprost—Pruritus—Sunitinib—pancreatic cancer	0.000404	0.00172	CcSEcCtD
Bimatoprost—Pain—Irinotecan—pancreatic cancer	0.000402	0.00171	CcSEcCtD
Bimatoprost—Dyspnoea—Fluorouracil—pancreatic cancer	0.000401	0.00171	CcSEcCtD
Bimatoprost—Somnolence—Fluorouracil—pancreatic cancer	0.0004	0.0017	CcSEcCtD
Bimatoprost—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000399	0.0017	CcSEcCtD
Bimatoprost—Erythema—Docetaxel—pancreatic cancer	0.000398	0.00169	CcSEcCtD
Bimatoprost—Dyspepsia—Fluorouracil—pancreatic cancer	0.000396	0.00169	CcSEcCtD
Bimatoprost—Nausea—Tamoxifen—pancreatic cancer	0.000396	0.00168	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000395	0.00168	CcSEcCtD
Bimatoprost—Pain—Gemcitabine—pancreatic cancer	0.000391	0.00167	CcSEcCtD
Bimatoprost—Nausea—Erlotinib—pancreatic cancer	0.000391	0.00167	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000388	0.00165	CcSEcCtD
Bimatoprost—Asthma—Epirubicin—pancreatic cancer	0.000385	0.00164	CcSEcCtD
Bimatoprost—Pain—Fluorouracil—pancreatic cancer	0.000385	0.00164	CcSEcCtD
Bimatoprost—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000381	0.00162	CcSEcCtD
Bimatoprost—Dry skin—Doxorubicin—pancreatic cancer	0.000378	0.00161	CcSEcCtD
Bimatoprost—Dizziness—Sunitinib—pancreatic cancer	0.000377	0.00161	CcSEcCtD
Bimatoprost—Bronchitis—Epirubicin—pancreatic cancer	0.00037	0.00158	CcSEcCtD
Bimatoprost—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000369	0.00157	CcSEcCtD
Bimatoprost—Rash—Sunitinib—pancreatic cancer	0.00036	0.00153	CcSEcCtD
Bimatoprost—Dermatitis—Sunitinib—pancreatic cancer	0.000359	0.00153	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000358	0.00152	CcSEcCtD
Bimatoprost—Headache—Sunitinib—pancreatic cancer	0.000357	0.00152	CcSEcCtD
Bimatoprost—Asthma—Doxorubicin—pancreatic cancer	0.000356	0.00152	CcSEcCtD
Bimatoprost—Palpitations—Docetaxel—pancreatic cancer	0.000352	0.0015	CcSEcCtD
Bimatoprost—Cough—Docetaxel—pancreatic cancer	0.000347	0.00148	CcSEcCtD
Bimatoprost—Hypertension—Docetaxel—pancreatic cancer	0.000344	0.00146	CcSEcCtD
Bimatoprost—Bronchitis—Doxorubicin—pancreatic cancer	0.000343	0.00146	CcSEcCtD
Bimatoprost—Chest pain—Docetaxel—pancreatic cancer	0.000339	0.00144	CcSEcCtD
Bimatoprost—Nausea—Sunitinib—pancreatic cancer	0.000339	0.00144	CcSEcCtD
Bimatoprost—Asthenia—Irinotecan—pancreatic cancer	0.000337	0.00144	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000336	0.00143	CcSEcCtD
Bimatoprost—Dry mouth—Docetaxel—pancreatic cancer	0.000331	0.00141	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000331	0.00141	CcSEcCtD
Bimatoprost—Asthenia—Gemcitabine—pancreatic cancer	0.000328	0.0014	CcSEcCtD
Bimatoprost—Pruritus—Gemcitabine—pancreatic cancer	0.000324	0.00138	CcSEcCtD
Bimatoprost—Infection—Docetaxel—pancreatic cancer	0.000323	0.00137	CcSEcCtD
Bimatoprost—Sinusitis—Epirubicin—pancreatic cancer	0.000322	0.00137	CcSEcCtD
Bimatoprost—Nervous system disorder—Docetaxel—pancreatic cancer	0.000318	0.00136	CcSEcCtD
Bimatoprost—Pruritus—Fluorouracil—pancreatic cancer	0.000318	0.00136	CcSEcCtD
Bimatoprost—Skin disorder—Docetaxel—pancreatic cancer	0.000315	0.00134	CcSEcCtD
Bimatoprost—Dizziness—Irinotecan—pancreatic cancer	0.000311	0.00132	CcSEcCtD
Bimatoprost—Rhinitis—Epirubicin—pancreatic cancer	0.000309	0.00132	CcSEcCtD
Bimatoprost—Pharyngitis—Epirubicin—pancreatic cancer	0.000306	0.0013	CcSEcCtD
Bimatoprost—Oedema peripheral—Epirubicin—pancreatic cancer	0.000304	0.00129	CcSEcCtD
Bimatoprost—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000303	0.00129	CcSEcCtD
Bimatoprost—Sinusitis—Doxorubicin—pancreatic cancer	0.000298	0.00127	CcSEcCtD
Bimatoprost—Dizziness—Fluorouracil—pancreatic cancer	0.000298	0.00127	CcSEcCtD
Bimatoprost—Visual impairment—Epirubicin—pancreatic cancer	0.000297	0.00127	CcSEcCtD
Bimatoprost—Rash—Irinotecan—pancreatic cancer	0.000296	0.00126	CcSEcCtD
Bimatoprost—Dermatitis—Irinotecan—pancreatic cancer	0.000296	0.00126	CcSEcCtD
Bimatoprost—Headache—Irinotecan—pancreatic cancer	0.000294	0.00125	CcSEcCtD
Bimatoprost—Insomnia—Docetaxel—pancreatic cancer	0.000294	0.00125	CcSEcCtD
Bimatoprost—Dyspnoea—Docetaxel—pancreatic cancer	0.00029	0.00123	CcSEcCtD
Bimatoprost—Somnolence—Docetaxel—pancreatic cancer	0.000289	0.00123	CcSEcCtD
Bimatoprost—Rash—Gemcitabine—pancreatic cancer	0.000289	0.00123	CcSEcCtD
Bimatoprost—Dermatitis—Gemcitabine—pancreatic cancer	0.000288	0.00123	CcSEcCtD
Bimatoprost—Eye disorder—Epirubicin—pancreatic cancer	0.000288	0.00123	CcSEcCtD
Bimatoprost—Headache—Gemcitabine—pancreatic cancer	0.000287	0.00122	CcSEcCtD
Bimatoprost—Rhinitis—Doxorubicin—pancreatic cancer	0.000286	0.00122	CcSEcCtD
Bimatoprost—Dyspepsia—Docetaxel—pancreatic cancer	0.000286	0.00122	CcSEcCtD
Bimatoprost—Rash—Fluorouracil—pancreatic cancer	0.000284	0.00121	CcSEcCtD
Bimatoprost—Dermatitis—Fluorouracil—pancreatic cancer	0.000283	0.00121	CcSEcCtD
Bimatoprost—Pharyngitis—Doxorubicin—pancreatic cancer	0.000283	0.00121	CcSEcCtD
Bimatoprost—Headache—Fluorouracil—pancreatic cancer	0.000282	0.0012	CcSEcCtD
Bimatoprost—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000281	0.0012	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00028	0.00119	CcSEcCtD
Bimatoprost—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00028	0.00119	CcSEcCtD
Bimatoprost—Angiopathy—Epirubicin—pancreatic cancer	0.00028	0.00119	CcSEcCtD
Bimatoprost—Nausea—Irinotecan—pancreatic cancer	0.000279	0.00119	CcSEcCtD
Bimatoprost—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000278	0.00118	CcSEcCtD
Bimatoprost—Pain—Docetaxel—pancreatic cancer	0.000278	0.00118	CcSEcCtD
Bimatoprost—Visual impairment—Doxorubicin—pancreatic cancer	0.000275	0.00117	CcSEcCtD
Bimatoprost—Nausea—Gemcitabine—pancreatic cancer	0.000272	0.00116	CcSEcCtD
Bimatoprost—Erythema—Epirubicin—pancreatic cancer	0.000268	0.00114	CcSEcCtD
Bimatoprost—Nausea—Fluorouracil—pancreatic cancer	0.000267	0.00114	CcSEcCtD
Bimatoprost—Eye disorder—Doxorubicin—pancreatic cancer	0.000267	0.00114	CcSEcCtD
Bimatoprost—Tension—Epirubicin—pancreatic cancer	0.000263	0.00112	CcSEcCtD
Bimatoprost—Nervousness—Epirubicin—pancreatic cancer	0.000261	0.00111	CcSEcCtD
Bimatoprost—Angiopathy—Doxorubicin—pancreatic cancer	0.000259	0.0011	CcSEcCtD
Bimatoprost—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000257	0.0011	CcSEcCtD
Bimatoprost—Vision blurred—Epirubicin—pancreatic cancer	0.000253	0.00108	CcSEcCtD
Bimatoprost—Erythema—Doxorubicin—pancreatic cancer	0.000248	0.00106	CcSEcCtD
Bimatoprost—Tension—Doxorubicin—pancreatic cancer	0.000244	0.00104	CcSEcCtD
Bimatoprost—Nervousness—Doxorubicin—pancreatic cancer	0.000241	0.00103	CcSEcCtD
Bimatoprost—Vertigo—Epirubicin—pancreatic cancer	0.000241	0.00103	CcSEcCtD
Bimatoprost—Palpitations—Epirubicin—pancreatic cancer	0.000237	0.00101	CcSEcCtD
Bimatoprost—Cough—Epirubicin—pancreatic cancer	0.000234	0.000998	CcSEcCtD
Bimatoprost—Vision blurred—Doxorubicin—pancreatic cancer	0.000234	0.000997	CcSEcCtD
Bimatoprost—Asthenia—Docetaxel—pancreatic cancer	0.000233	0.000993	CcSEcCtD
Bimatoprost—Hypertension—Epirubicin—pancreatic cancer	0.000232	0.000987	CcSEcCtD
Bimatoprost—Pruritus—Docetaxel—pancreatic cancer	0.00023	0.000979	CcSEcCtD
Bimatoprost—Chest pain—Epirubicin—pancreatic cancer	0.000229	0.000973	CcSEcCtD
Bimatoprost—Anxiety—Epirubicin—pancreatic cancer	0.000228	0.00097	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000227	0.000967	CcSEcCtD
Bimatoprost—Dry mouth—Epirubicin—pancreatic cancer	0.000223	0.000952	CcSEcCtD
Bimatoprost—Vertigo—Doxorubicin—pancreatic cancer	0.000223	0.00095	CcSEcCtD
Bimatoprost—Palpitations—Doxorubicin—pancreatic cancer	0.000219	0.000935	CcSEcCtD
Bimatoprost—Infection—Epirubicin—pancreatic cancer	0.000218	0.000927	CcSEcCtD
Bimatoprost—Cough—Doxorubicin—pancreatic cancer	0.000217	0.000923	CcSEcCtD
Bimatoprost—Nervous system disorder—Epirubicin—pancreatic cancer	0.000215	0.000915	CcSEcCtD
Bimatoprost—Dizziness—Docetaxel—pancreatic cancer	0.000215	0.000915	CcSEcCtD
Bimatoprost—Hypertension—Doxorubicin—pancreatic cancer	0.000214	0.000913	CcSEcCtD
Bimatoprost—Skin disorder—Epirubicin—pancreatic cancer	0.000213	0.000906	CcSEcCtD
Bimatoprost—Chest pain—Doxorubicin—pancreatic cancer	0.000211	0.000901	CcSEcCtD
Bimatoprost—Anxiety—Doxorubicin—pancreatic cancer	0.000211	0.000897	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00021	0.000894	CcSEcCtD
Bimatoprost—Dry mouth—Doxorubicin—pancreatic cancer	0.000207	0.000881	CcSEcCtD
Bimatoprost—Rash—Docetaxel—pancreatic cancer	0.000205	0.000872	CcSEcCtD
Bimatoprost—Dermatitis—Docetaxel—pancreatic cancer	0.000205	0.000871	CcSEcCtD
Bimatoprost—Headache—Docetaxel—pancreatic cancer	0.000203	0.000867	CcSEcCtD
Bimatoprost—Infection—Doxorubicin—pancreatic cancer	0.000201	0.000858	CcSEcCtD
Bimatoprost—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000199	0.000847	CcSEcCtD
Bimatoprost—Insomnia—Epirubicin—pancreatic cancer	0.000198	0.000844	CcSEcCtD
Bimatoprost—Skin disorder—Doxorubicin—pancreatic cancer	0.000197	0.000839	CcSEcCtD
Bimatoprost—Dyspnoea—Epirubicin—pancreatic cancer	0.000195	0.000832	CcSEcCtD
Bimatoprost—Somnolence—Epirubicin—pancreatic cancer	0.000195	0.000829	CcSEcCtD
Bimatoprost—Nausea—Docetaxel—pancreatic cancer	0.000193	0.000822	CcSEcCtD
Bimatoprost—Dyspepsia—Epirubicin—pancreatic cancer	0.000193	0.000821	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000189	0.000806	CcSEcCtD
Bimatoprost—Pain—Epirubicin—pancreatic cancer	0.000187	0.000798	CcSEcCtD
Bimatoprost—Insomnia—Doxorubicin—pancreatic cancer	0.000183	0.000781	CcSEcCtD
Bimatoprost—Dyspnoea—Doxorubicin—pancreatic cancer	0.000181	0.00077	CcSEcCtD
Bimatoprost—Somnolence—Doxorubicin—pancreatic cancer	0.00018	0.000768	CcSEcCtD
Bimatoprost—Dyspepsia—Doxorubicin—pancreatic cancer	0.000178	0.00076	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000175	0.000745	CcSEcCtD
Bimatoprost—Pain—Doxorubicin—pancreatic cancer	0.000173	0.000738	CcSEcCtD
Bimatoprost—Asthenia—Epirubicin—pancreatic cancer	0.000157	0.000669	CcSEcCtD
Bimatoprost—Pruritus—Epirubicin—pancreatic cancer	0.000155	0.00066	CcSEcCtD
Bimatoprost—Asthenia—Doxorubicin—pancreatic cancer	0.000145	0.000619	CcSEcCtD
Bimatoprost—Dizziness—Epirubicin—pancreatic cancer	0.000145	0.000617	CcSEcCtD
Bimatoprost—Pruritus—Doxorubicin—pancreatic cancer	0.000143	0.000611	CcSEcCtD
Bimatoprost—Rash—Epirubicin—pancreatic cancer	0.000138	0.000588	CcSEcCtD
Bimatoprost—Dermatitis—Epirubicin—pancreatic cancer	0.000138	0.000588	CcSEcCtD
Bimatoprost—Headache—Epirubicin—pancreatic cancer	0.000137	0.000585	CcSEcCtD
Bimatoprost—Dizziness—Doxorubicin—pancreatic cancer	0.000134	0.000571	CcSEcCtD
Bimatoprost—Nausea—Epirubicin—pancreatic cancer	0.00013	0.000554	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000128	0.000531	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JAG2—pancreatic cancer	0.000128	0.00053	CbGpPWpGaD
Bimatoprost—Rash—Doxorubicin—pancreatic cancer	0.000128	0.000544	CcSEcCtD
Bimatoprost—Dermatitis—Doxorubicin—pancreatic cancer	0.000128	0.000544	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—SHH—pancreatic cancer	0.000127	0.000528	CbGpPWpGaD
Bimatoprost—Headache—Doxorubicin—pancreatic cancer	0.000127	0.000541	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH4—pancreatic cancer	0.000127	0.000524	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MEN1—pancreatic cancer	0.000126	0.000522	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IAPP—pancreatic cancer	0.000126	0.000521	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGTR1—pancreatic cancer	0.000126	0.00052	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SHH—pancreatic cancer	0.000125	0.000517	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000124	0.000513	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STK11—pancreatic cancer	0.000124	0.000513	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IAPP—pancreatic cancer	0.000123	0.00051	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTHLH—pancreatic cancer	0.000121	0.0005	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTCH1—pancreatic cancer	0.000121	0.0005	CbGpPWpGaD
Bimatoprost—Nausea—Doxorubicin—pancreatic cancer	0.00012	0.000513	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—SHH—pancreatic cancer	0.00012	0.000498	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH4—pancreatic cancer	0.000119	0.000495	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IAPP—pancreatic cancer	0.000119	0.000492	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTHLH—pancreatic cancer	0.000118	0.00049	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTCH1—pancreatic cancer	0.000118	0.00049	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000116	0.000482	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CD44—pancreatic cancer	0.000116	0.00048	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTHLH—pancreatic cancer	0.000114	0.000472	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTCH1—pancreatic cancer	0.000114	0.000472	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000113	0.00047	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000112	0.000466	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000112	0.000462	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GCG—pancreatic cancer	0.000111	0.000461	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SST—pancreatic cancer	0.00011	0.000458	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SMAD4—pancreatic cancer	0.000109	0.000453	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000109	0.000451	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SMAD4—pancreatic cancer	0.000108	0.000449	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SST—pancreatic cancer	0.000108	0.000448	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JAG1—pancreatic cancer	0.000108	0.000448	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH3—pancreatic cancer	0.000108	0.000446	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000107	0.000444	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HES1—pancreatic cancer	0.000107	0.000442	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000107	0.000442	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HES1—pancreatic cancer	0.000106	0.000439	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JAG1—pancreatic cancer	0.000106	0.000438	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000105	0.000436	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—STK11—pancreatic cancer	0.000104	0.000433	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SST—pancreatic cancer	0.000104	0.000432	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JAG1—pancreatic cancer	0.000102	0.000423	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CNR1—pancreatic cancer	0.000102	0.000422	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH3—pancreatic cancer	0.000102	0.000421	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000101	0.00042	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CNR1—pancreatic cancer	9.97e-05	0.000413	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CG—pancreatic cancer	9.89e-05	0.00041	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GCG—pancreatic cancer	9.84e-05	0.000408	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.81e-05	0.000406	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL8—pancreatic cancer	9.74e-05	0.000404	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CG—pancreatic cancer	9.68e-05	0.000401	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GCG—pancreatic cancer	9.63e-05	0.000399	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CNR1—pancreatic cancer	9.62e-05	0.000399	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.57e-05	0.000397	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGTR1—pancreatic cancer	9.39e-05	0.000389	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.37e-05	0.000388	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TERT—pancreatic cancer	9.35e-05	0.000387	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GCG—pancreatic cancer	9.29e-05	0.000385	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TERT—pancreatic cancer	9.27e-05	0.000384	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STK11—pancreatic cancer	9.25e-05	0.000383	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGTR1—pancreatic cancer	9.19e-05	0.000381	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STK11—pancreatic cancer	9.05e-05	0.000375	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TYMS—pancreatic cancer	8.99e-05	0.000373	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HIF1A—pancreatic cancer	8.94e-05	0.000371	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TSC2—pancreatic cancer	8.92e-05	0.00037	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HIF1A—pancreatic cancer	8.87e-05	0.000367	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGTR1—pancreatic cancer	8.86e-05	0.000367	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TSC2—pancreatic cancer	8.84e-05	0.000367	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STK11—pancreatic cancer	8.74e-05	0.000362	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOE—pancreatic cancer	8.73e-05	0.000362	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CD—pancreatic cancer	8.69e-05	0.00036	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOE—pancreatic cancer	8.65e-05	0.000359	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CD—pancreatic cancer	8.51e-05	0.000353	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KDR—pancreatic cancer	8.48e-05	0.000351	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.34e-05	0.000346	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.17e-05	0.000338	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SMAD4—pancreatic cancer	8.1e-05	0.000336	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NFKBIA—pancreatic cancer	8.06e-05	0.000334	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOTCH1—pancreatic cancer	8.05e-05	0.000334	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL8—pancreatic cancer	8.02e-05	0.000332	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOTCH1—pancreatic cancer	7.99e-05	0.000331	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SMAD4—pancreatic cancer	7.93e-05	0.000329	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HES1—pancreatic cancer	7.91e-05	0.000328	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.85e-05	0.000325	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CG—pancreatic cancer	7.81e-05	0.000324	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—NRAS—pancreatic cancer	7.81e-05	0.000324	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGF—pancreatic cancer	7.79e-05	0.000323	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HES1—pancreatic cancer	7.74e-05	0.000321	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGF—pancreatic cancer	7.72e-05	0.00032	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SMAD4—pancreatic cancer	7.65e-05	0.000317	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CB—pancreatic cancer	7.58e-05	0.000314	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HES1—pancreatic cancer	7.47e-05	0.00031	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.42e-05	0.000307	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOE—pancreatic cancer	7.31e-05	0.000303	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—pancreatic cancer	7.28e-05	0.000302	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—pancreatic cancer	7.13e-05	0.000295	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—pancreatic cancer	7.12e-05	0.000295	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TERT—pancreatic cancer	6.93e-05	0.000287	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CD—pancreatic cancer	6.92e-05	0.000287	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.92e-05	0.000287	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CD—pancreatic cancer	6.87e-05	0.000285	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.8e-05	0.000282	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TERT—pancreatic cancer	6.79e-05	0.000281	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—KRAS—pancreatic cancer	6.72e-05	0.000279	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HIF1A—pancreatic cancer	6.63e-05	0.000275	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TSC2—pancreatic cancer	6.61e-05	0.000274	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—pancreatic cancer	6.6e-05	0.000273	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TERT—pancreatic cancer	6.55e-05	0.000271	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIF1A—pancreatic cancer	6.49e-05	0.000269	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TSC2—pancreatic cancer	6.47e-05	0.000268	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOE—pancreatic cancer	6.47e-05	0.000268	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARG—pancreatic cancer	6.37e-05	0.000264	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KDR—pancreatic cancer	6.34e-05	0.000263	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOE—pancreatic cancer	6.33e-05	0.000263	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIF1A—pancreatic cancer	6.26e-05	0.000259	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TSC2—pancreatic cancer	6.25e-05	0.000259	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KDR—pancreatic cancer	6.21e-05	0.000257	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—pancreatic cancer	6.18e-05	0.000256	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOE—pancreatic cancer	6.11e-05	0.000253	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CB—pancreatic cancer	6.04e-05	0.00025	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NFKBIA—pancreatic cancer	6.03e-05	0.00025	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KDR—pancreatic cancer	5.99e-05	0.000248	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CB—pancreatic cancer	5.98e-05	0.000248	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—pancreatic cancer	5.98e-05	0.000248	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH1—pancreatic cancer	5.97e-05	0.000248	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NFKBIA—pancreatic cancer	5.9e-05	0.000245	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH1—pancreatic cancer	5.85e-05	0.000242	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—pancreatic cancer	5.84e-05	0.000242	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—NRAS—pancreatic cancer	5.84e-05	0.000242	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CD—pancreatic cancer	5.8e-05	0.00024	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGF—pancreatic cancer	5.77e-05	0.000239	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—pancreatic cancer	5.75e-05	0.000238	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—pancreatic cancer	5.72e-05	0.000237	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—NRAS—pancreatic cancer	5.72e-05	0.000237	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HRAS—pancreatic cancer	5.71e-05	0.000237	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NFKBIA—pancreatic cancer	5.69e-05	0.000236	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGF—pancreatic cancer	5.65e-05	0.000234	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH1—pancreatic cancer	5.64e-05	0.000234	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—pancreatic cancer	5.56e-05	0.00023	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—pancreatic cancer	5.52e-05	0.000229	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—pancreatic cancer	5.5e-05	0.000228	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGF—pancreatic cancer	5.45e-05	0.000226	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCND1—pancreatic cancer	5.36e-05	0.000222	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CTNNB1—pancreatic cancer	5.35e-05	0.000222	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—pancreatic cancer	5.32e-05	0.000221	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CTNNB1—pancreatic cancer	5.31e-05	0.00022	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTEN—pancreatic cancer	5.22e-05	0.000216	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—pancreatic cancer	5.21e-05	0.000216	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—pancreatic cancer	5.2e-05	0.000216	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTEN—pancreatic cancer	5.17e-05	0.000214	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CD—pancreatic cancer	5.13e-05	0.000213	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.09e-05	0.000211	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CB—pancreatic cancer	5.05e-05	0.000209	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—pancreatic cancer	5.05e-05	0.000209	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—KRAS—pancreatic cancer	5.03e-05	0.000208	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CD—pancreatic cancer	5.03e-05	0.000208	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—pancreatic cancer	5.01e-05	0.000208	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.98e-05	0.000206	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—KRAS—pancreatic cancer	4.92e-05	0.000204	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CD—pancreatic cancer	4.85e-05	0.000201	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SRC—pancreatic cancer	4.84e-05	0.0002	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SRC—pancreatic cancer	4.8e-05	0.000199	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—pancreatic cancer	4.67e-05	0.000194	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—pancreatic cancer	4.66e-05	0.000193	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NRAS—pancreatic cancer	4.65e-05	0.000193	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—pancreatic cancer	4.63e-05	0.000192	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—pancreatic cancer	4.62e-05	0.000191	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NRAS—pancreatic cancer	4.61e-05	0.000191	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.52e-05	0.000187	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CB—pancreatic cancer	4.48e-05	0.000185	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CB—pancreatic cancer	4.38e-05	0.000182	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTEN—pancreatic cancer	4.37e-05	0.000181	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—pancreatic cancer	4.33e-05	0.00018	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—pancreatic cancer	4.32e-05	0.000179	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—pancreatic cancer	4.3e-05	0.000178	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—pancreatic cancer	4.3e-05	0.000178	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—pancreatic cancer	4.29e-05	0.000178	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HRAS—pancreatic cancer	4.27e-05	0.000177	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—pancreatic cancer	4.24e-05	0.000176	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CB—pancreatic cancer	4.23e-05	0.000175	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—pancreatic cancer	4.21e-05	0.000174	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—pancreatic cancer	4.2e-05	0.000174	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HRAS—pancreatic cancer	4.18e-05	0.000173	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—pancreatic cancer	4.15e-05	0.000172	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—pancreatic cancer	4.12e-05	0.000171	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—pancreatic cancer	4.07e-05	0.000169	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—pancreatic cancer	4.06e-05	0.000168	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—pancreatic cancer	4.03e-05	0.000167	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCND1—pancreatic cancer	4.01e-05	0.000166	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KRAS—pancreatic cancer	4e-05	0.000166	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KRAS—pancreatic cancer	3.97e-05	0.000165	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CTNNB1—pancreatic cancer	3.97e-05	0.000164	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCND1—pancreatic cancer	3.92e-05	0.000163	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—pancreatic cancer	3.89e-05	0.000161	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—pancreatic cancer	3.89e-05	0.000161	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CTNNB1—pancreatic cancer	3.88e-05	0.000161	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTEN—pancreatic cancer	3.87e-05	0.00016	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—pancreatic cancer	3.81e-05	0.000158	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTEN—pancreatic cancer	3.79e-05	0.000157	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCND1—pancreatic cancer	3.78e-05	0.000157	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—pancreatic cancer	3.77e-05	0.000156	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CTNNB1—pancreatic cancer	3.75e-05	0.000155	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—pancreatic cancer	3.69e-05	0.000153	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—pancreatic cancer	3.68e-05	0.000152	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—pancreatic cancer	3.67e-05	0.000152	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTEN—pancreatic cancer	3.65e-05	0.000151	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—pancreatic cancer	3.65e-05	0.000151	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SRC—pancreatic cancer	3.59e-05	0.000149	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—pancreatic cancer	3.53e-05	0.000146	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SRC—pancreatic cancer	3.51e-05	0.000146	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—pancreatic cancer	3.49e-05	0.000145	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—pancreatic cancer	3.46e-05	0.000143	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NRAS—pancreatic cancer	3.45e-05	0.000143	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—pancreatic cancer	3.42e-05	0.000142	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HRAS—pancreatic cancer	3.4e-05	0.000141	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SRC—pancreatic cancer	3.39e-05	0.00014	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—pancreatic cancer	3.39e-05	0.00014	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NRAS—pancreatic cancer	3.38e-05	0.00014	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HRAS—pancreatic cancer	3.38e-05	0.00014	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—pancreatic cancer	3.3e-05	0.000137	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—pancreatic cancer	3.27e-05	0.000135	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NRAS—pancreatic cancer	3.26e-05	0.000135	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—pancreatic cancer	3.21e-05	0.000133	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—pancreatic cancer	3.21e-05	0.000133	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—pancreatic cancer	3.15e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—pancreatic cancer	3.14e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—pancreatic cancer	3.14e-05	0.00013	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—pancreatic cancer	3.08e-05	0.000128	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—pancreatic cancer	3.08e-05	0.000128	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—pancreatic cancer	3.03e-05	0.000126	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—pancreatic cancer	3.03e-05	0.000125	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—pancreatic cancer	3.01e-05	0.000125	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—pancreatic cancer	2.98e-05	0.000124	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KRAS—pancreatic cancer	2.97e-05	0.000123	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—pancreatic cancer	2.97e-05	0.000123	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KRAS—pancreatic cancer	2.91e-05	0.00012	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KRAS—pancreatic cancer	2.8e-05	0.000116	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—pancreatic cancer	2.73e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—pancreatic cancer	2.67e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—pancreatic cancer	2.64e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—pancreatic cancer	2.58e-05	0.000107	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—pancreatic cancer	2.58e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HRAS—pancreatic cancer	2.52e-05	0.000105	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—pancreatic cancer	2.52e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—pancreatic cancer	2.49e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HRAS—pancreatic cancer	2.47e-05	0.000102	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HRAS—pancreatic cancer	2.38e-05	9.88e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—pancreatic cancer	2.23e-05	9.24e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—pancreatic cancer	2.18e-05	9.04e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—pancreatic cancer	2.1e-05	8.72e-05	CbGpPWpGaD
